/Becton%20Dickinson%20%26%20Co_%20office%20building-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Becton, Dickinson, and Company (BDX), headquartered in Franklin Lakes, New Jersey, is a global medical technology company specializing in developing and manufacturing innovative medical devices, laboratory equipment, and diagnostic products. With a market cap of $67.24 billion, BDX is a major player in the healthcare industry, renowned for its extensive portfolio of products that enhance medication management, infection prevention, and diagnostic accuracy.
Companies valued at $10 billion or more are typically classified as "large-cap stocks," and Becton, Dickinson, and Company comfortably fit this category. BDX has established a strong market presence driven by its broad portfolio of medical devices, diagnostic products, and life sciences solutions, as well as its commitment to advancing healthcare and improving patient outcomes worldwide.
